Brain

Music and psychedelics go hand-in-hand. Could both have a healing effect?

London-based startup Wavepaths is creating a new kind of music technology explicitly designed for psychedelic therapy.

An experimental drug that addresses anhedonia could increase the brain’s capacity to experience pleasure and herald a new era of precision medicine in psychiatry.

Psilocybin, MDMA, and ketamine can lead to a new sense of self and a release from rigid rules for people with anorexia, bulimia, and binge-eating disorder.

After 175 years, the medical art with a strange and dark history is getting a lot more precise.

We ask the experts what’s coming in the next 12 months.

Growing interest in psychedelic therapy reveals two different visions of the future: one of spiritual interconnectedness and one of sober neurochemistry.

The aspects that make them most creative may also be their biggest risk.

The fact that no two are alike could be the key to designing AIs that can adapt to change.

Major corporations are applying the lessons of cognitive neuroscience to get the American public buying.